purpose: we investigated the association of financial toxicity (FT) with the health-related quality of life (HRQoL) profile of patients with hematologic malignancies treated in a universal health care system. methods: we did a secondary analysis of six multicenter studies enrolling patients with hematologic malignancies. FT was evaluated using the financial difficulties item of the european organisation for research and treatment of cancer quality of life questionnaire core 30 (EORTC QLQ-C30). multivariable linear regression models were used to assess the mean differences in HRQoL scores between patients with or without FT, while adjusting for key potential confounding factors. we also examined the prevalence of clinically important problem...
In oncology, the term ‘financial toxicity’ basically means the financial hardship or financial burde...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...
Purpose: This study examined the prevalence of financial toxicity (FT) and associated factors among ...
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
Purpose: Financial toxicity (FT) is a significant concern for patients with cancer. We reviewed pros...
Introduction This study examined the prevalence of financial toxicity (FT) its association with heal...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Traditionally, economic evaluations are based on clinical trials with well-defined patient populatio...
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: The aim of this stud...
BackgroundIn the US, medical costs for cancer patients have grown from $27 billion in 1990 to $174 b...
AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxi...
Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM)...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
In oncology, the term ‘financial toxicity’ basically means the financial hardship or financial burde...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...
Purpose: This study examined the prevalence of financial toxicity (FT) and associated factors among ...
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
Purpose: Financial toxicity (FT) is a significant concern for patients with cancer. We reviewed pros...
Introduction This study examined the prevalence of financial toxicity (FT) its association with heal...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Traditionally, economic evaluations are based on clinical trials with well-defined patient populatio...
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: The aim of this stud...
BackgroundIn the US, medical costs for cancer patients have grown from $27 billion in 1990 to $174 b...
AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxi...
Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM)...
Pauge S, Surmann B, Mehlis K, et al. Patient-Reported Financial Distress in Cancer: A Systematic Rev...
In oncology, the term ‘financial toxicity’ basically means the financial hardship or financial burde...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...